SCHEMBL1848657

SCHEMBL1848657

CCC(=O)NOCCO

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL839806 0.83
SCHEMBL9183337 0.82 CNR2 (0.60)
SCHEMBL15282090 0.79 CNR2 (0.45)
SCHEMBL30805168 0.79 TSHR (0.36)
SCHEMBL30195171 0.79 CNR2 (0.71)
SCHEMBL841621 0.77
SCHEMBL15296632 0.76
SCHEMBL4141685 0.76 CNR2 (0.50)
SCHEMBL13191371 0.76 CHRM2 (0.42)
SCHEMBL28945729 0.76 CNR2 (0.50)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024054845-A1 MACROCYCIC COMPOUNDS, COMPOSITIONS, AND METHODS OF USING THEREOF SIONNA THERAPEUTICS (US) 2024-03-14 WO disclosed
US-9937158-B2 Benzoheterocyclic compounds and use thereof SHANGHAI KECHOW PHARMA, INC. (CN) 2018-04-10 US disclosed
EP-2324028-A2 THERAPEUTIC AGENTS 414 AstraZeneca AB (SE) 2011-05-25 EP disclosed
WO-2010015849-A2 THERAPEUTIC AGENTS 414 ASTRAZENECA AB (SE) 2010-02-11 WO disclosed